ARK holds 9.59% of Pacific Biosciences stock
ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 29,781,416 shares of Pacific Biosciences of California, Inc. common stock, representing 9.59% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ARK Investment Management LLC and Catherine D. Wood report beneficial ownership of 29,781,416 shares of Pacific Biosciences of California, Inc. common stock, representing 9.59% of the class. ARK has sole voting power over 27,781,961 shares and sole dispositive power over 29,781,416 shares, while Catherine D. Wood reports shared voting and dispositive power over these holdings.
Key Figures
Key Terms
beneficially owned financial
sole voting power financial
sole dispositive power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of PACB does ARK Investment Management currently own?
What voting and dispositive power does Catherine D. Wood report over PACB?
Who are the reporting persons on this PACB Schedule 13G/A filing?
What type of security in PACB is reported as owned by ARK and Catherine Wood?
AI-generated analysis. How Rhea-AI works. Not financial advice.